The implications of a pathological complete response of the primary tumour after neoadjuvant chemotherapy for breast cancer on axillary surgery.
Mina M G YoussefAhmed A MetwallyTamer M ManiePublished in: Journal of the Egyptian National Cancer Institute (2021)
A less invasive axillary surgery may be safely recommended in selected group of node-positive patients after neoadjuvant chemotherapy when the primary tumour shows complete response. This group may include HER2-positive, ER-negative and grade 3 tumours. Less response is expected in ER-positive and lobular carcinoma even with complete response in the primary.
Keyphrases
- neoadjuvant chemotherapy
- lymph node
- sentinel lymph node
- locally advanced
- minimally invasive
- coronary artery bypass
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- rectal cancer
- breast cancer cells
- radiation therapy
- prognostic factors
- surgical site infection
- endoplasmic reticulum
- young adults
- atrial fibrillation